Status:
COMPLETED
Impact of Oligonol to Cardiometabolic Risk and Muscular Health
Lead Sponsor:
National Yang Ming Chiao Tung University
Conditions:
Muscle Loss
Muscle Weakness
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This project will mainly focus on Middle and old-aged adults, and examine whether Cardiovascular and metabolic risks can be reduced. In the meanwhile, this project will develop strategies for improvin...
Detailed Description
Cardiovascular diseases are common among the elder. However, previous researches mainly focus on observational research or small scale clinical trial, and the subjects are mainly youth. Therefore, thi...
Eligibility Criteria
Inclusion
- People who aged more than 50 years
- Patients with following characteristics:
- feeling loss in activity.
- detecting decline in self's walking speed.
- feeling tired of doing everything.
- having fallen down last year.
- People can accept undergoing MRI
- People willing to follow the program and cooperate with us for following tracking.
- People who are neither vegan nor vegetarian
Exclusion
- Walking speed less than 0.3m/s
- People with any disease affecting their limbs, including:
- having fracture on limbs in the past 6 months.
- having severe arthritis in the past 6 months
- any other whom PI recognized as weak control of their nervous system( e.g.: Parkinson's disease and stroke).
- People with intermittent limp caused by peripheral artery diseases
- People with weak control of mental disorder
- People with weak control of Cardiopulmonary disease
- People with weak control of Malignant tumor
- People with weak control of kidney diseases (GFR \< 30 mL/min/1.73 m2 for at least 3 months)
- People with visual impairment and hearing disorder who cannot complete the program.
- People who are unable to undertake MRI
- Any other condition that PI recognized as not suitable.
Key Trial Info
Start Date :
December 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03788577
Start Date
December 4 2018
End Date
April 1 2020
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veteran General Hospital
Taipei, Taiwan, 112